Central Venous Catheter Thrombosis
20
1
1
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
1 terminated out of 20 trials
90.9%
+4.4% vs benchmark
15%
3 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (20)
Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters
THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
CLiCK in the Critical Care Unit
Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines
Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit
Thrombotic Complications After Central Venous Catheterization
Daily Ultrasound-screening for CVC-related Thrombosis
Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter
Central Venous Catheter-related Complications in Patients Under Anticancer Treatment
The Central Venous Catheter Related Complications in Critically Ill Patients
Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection
HoloStream Study - Video Capture Device Usage
The Relationship Between the Lack of AT-Ⅲ, PC, PS Activity and PICC-related Thrombosis
Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion
Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery
Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)
Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis
Early Detection of PICC-related Deep Vein Thrombosis by US Surveillance: an Effective Approach for Secondary Prevention?